STK11 and cancer: The primary pathogenic mechanism involves loss-of-function mutations in the STK11/LKB1 gene, which disrupts multiple signaling pathways, including AMPK-mTOR, Wnt/β-catenin, and PI3K/AKT, leading to polyp formation and increased cancer susceptibility (1, 3, 4).